Cite Filings / AMLX / 0000950170-23-015281

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Amylyx Pharmaceuticals, Inc. Filed 2023-04-27 Acc 0000950170-23-015281

Documents 1

DEFA14A Proxy Materials , amlx-defa14a-2023-additi.htm

Around this filing

2024-04-24 DEFA14A Proxy Materials
2023-04-27 ARS Annual Report to Security Holders
2023-04-27 DEFA14A Proxy Materials
2023-04-27 DEF 14A Proxy Statement
2023-04-26 4/A Chief Financial Officer acquired 19,482 shares (conversion)
2023-04-26 3/A 3/A
2022-04-29 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading amlx-defa14a-2023-additi.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…